Abstract
Summary
Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thus preventing activation of the GPIIb/IIIa receptor complex. As a result, inhibition of ADP-mediated platelet activation and aggregation occurs. Prasugrel was developed by Daiichi Sankyo Co. and is currently marketed in the United States and Canada in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). FDA approved in 2009.
LPI (LP Information)' newest research report, the “Prasugrel Hydrochloride Industry Forecast” looks at past sales and reviews total world Prasugrel Hydrochloride sales in 2022, providing a comprehensive analysis by region and market sector of projected Prasugrel Hydrochloride sales for 2023 through 2029. With Prasugrel Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prasugrel Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Prasugrel Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prasugrel Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Prasugrel Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prasugrel Hydrochloride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prasugrel Hydrochloride.
The global Prasugrel Hydrochloride market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Prasugrel Hydrochloride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Prasugrel Hydrochloride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Prasugrel Hydrochloride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Prasugrel Hydrochloride players cover Daiichi Sankyo, Amneal Pharmaceuticals, Apotex, Ube, Ascend Laboratories, Liberty Pharmaceuticals and Panacea Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Prasugrel Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
5mg
10mg
Segmentation by application
Hospital
Drugs Store
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Daiichi Sankyo
Amneal Pharmaceuticals
Apotex
Ube
Ascend Laboratories
Liberty Pharmaceuticals
Panacea Biotec
Key Questions Addressed in this Report
What is the 10-year outlook for the global Prasugrel Hydrochloride market?
What factors are driving Prasugrel Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prasugrel Hydrochloride market opportunities vary by end market size?
How does Prasugrel Hydrochloride break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Prasugrel Hydrochloride Industry Forecast” looks at past sales and reviews total world Prasugrel Hydrochloride sales in 2022, providing a comprehensive analysis by region and market sector of projected Prasugrel Hydrochloride sales for 2023 through 2029. With Prasugrel Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prasugrel Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Prasugrel Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prasugrel Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Prasugrel Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prasugrel Hydrochloride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prasugrel Hydrochloride.
The global Prasugrel Hydrochloride market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Prasugrel Hydrochloride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Prasugrel Hydrochloride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Prasugrel Hydrochloride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Prasugrel Hydrochloride players cover Daiichi Sankyo, Amneal Pharmaceuticals, Apotex, Ube, Ascend Laboratories, Liberty Pharmaceuticals and Panacea Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Prasugrel Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
5mg
10mg
Segmentation by application
Hospital
Drugs Store
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Daiichi Sankyo
Amneal Pharmaceuticals
Apotex
Ube
Ascend Laboratories
Liberty Pharmaceuticals
Panacea Biotec
Key Questions Addressed in this Report
What is the 10-year outlook for the global Prasugrel Hydrochloride market?
What factors are driving Prasugrel Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prasugrel Hydrochloride market opportunities vary by end market size?
How does Prasugrel Hydrochloride break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prasugrel Hydrochloride Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Prasugrel Hydrochloride by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Prasugrel Hydrochloride by Country/Region, 2018, 2022 & 2029
2.2 Prasugrel Hydrochloride Segment by Type
2.2.1 5mg
2.2.2 10mg
2.3 Prasugrel Hydrochloride Sales by Type
2.3.1 Global Prasugrel Hydrochloride Sales Market Share by Type (2018-2023)
2.3.2 Global Prasugrel Hydrochloride Revenue and Market Share by Type (2018-2023)
2.3.3 Global Prasugrel Hydrochloride Sale Price by Type (2018-2023)
2.4 Prasugrel Hydrochloride Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Prasugrel Hydrochloride Sales by Application
2.5.1 Global Prasugrel Hydrochloride Sale Market Share by Application (2018-2023)
2.5.2 Global Prasugrel Hydrochloride Revenue and Market Share by Application (2018-2023)
2.5.3 Global Prasugrel Hydrochloride Sale Price by Application (2018-2023)
3 Global Prasugrel Hydrochloride by Company
3.1 Global Prasugrel Hydrochloride Breakdown Data by Company
3.1.1 Global Prasugrel Hydrochloride Annual Sales by Company (2018-2023)
3.1.2 Global Prasugrel Hydrochloride Sales Market Share by Company (2018-2023)
3.2 Global Prasugrel Hydrochloride Annual Revenue by Company (2018-2023)
3.2.1 Global Prasugrel Hydrochloride Revenue by Company (2018-2023)
3.2.2 Global Prasugrel Hydrochloride Revenue Market Share by Company (2018-2023)
3.3 Global Prasugrel Hydrochloride Sale Price by Company
3.4 Key Manufacturers Prasugrel Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prasugrel Hydrochloride Product Location Distribution
3.4.2 Players Prasugrel Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prasugrel Hydrochloride by Geographic Region
4.1 World Historic Prasugrel Hydrochloride Market Size by Geographic Region (2018-2023)
4.1.1 Global Prasugrel Hydrochloride Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Prasugrel Hydrochloride Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Prasugrel Hydrochloride Market Size by Country/Region (2018-2023)
4.2.1 Global Prasugrel Hydrochloride Annual Sales by Country/Region (2018-2023)
4.2.2 Global Prasugrel Hydrochloride Annual Revenue by Country/Region (2018-2023)
4.3 Americas Prasugrel Hydrochloride Sales Growth
4.4 APAC Prasugrel Hydrochloride Sales Growth
4.5 Europe Prasugrel Hydrochloride Sales Growth
4.6 Middle East & Africa Prasugrel Hydrochloride Sales Growth
5 Americas
5.1 Americas Prasugrel Hydrochloride Sales by Country
5.1.1 Americas Prasugrel Hydrochloride Sales by Country (2018-2023)
5.1.2 Americas Prasugrel Hydrochloride Revenue by Country (2018-2023)
5.2 Americas Prasugrel Hydrochloride Sales by Type
5.3 Americas Prasugrel Hydrochloride Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prasugrel Hydrochloride Sales by Region
6.1.1 APAC Prasugrel Hydrochloride Sales by Region (2018-2023)
6.1.2 APAC Prasugrel Hydrochloride Revenue by Region (2018-2023)
6.2 APAC Prasugrel Hydrochloride Sales by Type
6.3 APAC Prasugrel Hydrochloride Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prasugrel Hydrochloride by Country
7.1.1 Europe Prasugrel Hydrochloride Sales by Country (2018-2023)
7.1.2 Europe Prasugrel Hydrochloride Revenue by Country (2018-2023)
7.2 Europe Prasugrel Hydrochloride Sales by Type
7.3 Europe Prasugrel Hydrochloride Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prasugrel Hydrochloride by Country
8.1.1 Middle East & Africa Prasugrel Hydrochloride Sales by Country (2018-2023)
8.1.2 Middle East & Africa Prasugrel Hydrochloride Revenue by Country (2018-2023)
8.2 Middle East & Africa Prasugrel Hydrochloride Sales by Type
8.3 Middle East & Africa Prasugrel Hydrochloride Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prasugrel Hydrochloride
10.3 Manufacturing Process Analysis of Prasugrel Hydrochloride
10.4 Industry Chain Structure of Prasugrel Hydrochloride
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prasugrel Hydrochloride Distributors
11.3 Prasugrel Hydrochloride Customer
12 World Forecast Review for Prasugrel Hydrochloride by Geographic Region
12.1 Global Prasugrel Hydrochloride Market Size Forecast by Region
12.1.1 Global Prasugrel Hydrochloride Forecast by Region (2024-2029)
12.1.2 Global Prasugrel Hydrochloride Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prasugrel Hydrochloride Forecast by Type
12.7 Global Prasugrel Hydrochloride Forecast by Application
13 Key Players Analysis
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Prasugrel Hydrochloride Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Amneal Pharmaceuticals
13.2.1 Amneal Pharmaceuticals Company Information
13.2.2 Amneal Pharmaceuticals Prasugrel Hydrochloride Product Portfolios and Specifications
13.2.3 Amneal Pharmaceuticals Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amneal Pharmaceuticals Main Business Overview
13.2.5 Amneal Pharmaceuticals Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Prasugrel Hydrochloride Product Portfolios and Specifications
13.3.3 Apotex Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Ube
13.4.1 Ube Company Information
13.4.2 Ube Prasugrel Hydrochloride Product Portfolios and Specifications
13.4.3 Ube Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ube Main Business Overview
13.4.5 Ube Latest Developments
13.5 Ascend Laboratories
13.5.1 Ascend Laboratories Company Information
13.5.2 Ascend Laboratories Prasugrel Hydrochloride Product Portfolios and Specifications
13.5.3 Ascend Laboratories Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ascend Laboratories Main Business Overview
13.5.5 Ascend Laboratories Latest Developments
13.6 Liberty Pharmaceuticals
13.6.1 Liberty Pharmaceuticals Company Information
13.6.2 Liberty Pharmaceuticals Prasugrel Hydrochloride Product Portfolios and Specifications
13.6.3 Liberty Pharmaceuticals Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Liberty Pharmaceuticals Main Business Overview
13.6.5 Liberty Pharmaceuticals Latest Developments
13.7 Panacea Biotec
13.7.1 Panacea Biotec Company Information
13.7.2 Panacea Biotec Prasugrel Hydrochloride Product Portfolios and Specifications
13.7.3 Panacea Biotec Prasugrel Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Panacea Biotec Main Business Overview
13.7.5 Panacea Biotec Latest Developments
14 Research Findings and Conclusion